Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Galmed Pharmaceuticals stock

Learn how to easily invest in Galmed Pharmaceuticals stock.

Galmed Pharmaceuticals Ltd is a biotechnology business based in the US. Galmed Pharmaceuticals shares (GLMD) are listed on the NASDAQ and all prices are listed in US Dollars. Galmed Pharmaceuticals employs 18 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Galmed Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GLMD – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Galmed Pharmaceuticals stock price (NASDAQ: GLMD)

Use our graph to track the performance of GLMD stocks over time.

Galmed Pharmaceuticals shares at a glance

Information last updated 2022-01-25.
Latest market close$1.52
52-week range$1.31 - $6.25
50-day moving average $2.16
200-day moving average $2.71
Wall St. target price$17.60
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.49

Buy Galmed Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Stocks
$0
0%
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$0
$1 per month
$5
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Public
Stocks, ETFs, Cryptocurrency
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Galmed Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Galmed Pharmaceuticals price performance over time

Historical closes compared with the close of $1.52 from 2022-01-25

1 week (2022-01-19) -5.30%
1 month (2021-12-23) -25.12%
3 months (2021-10-26) -38.21%
6 months (2021-07-26) -41.09%
1 year (2021-01-26) -59.52%
2 years (2020-01-24) -73.66%
3 years (2019-01-25) 7.64
5 years (2017-01-26) 3.95

Galmed Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -42.84%
Return on equity TTM -77.28%
Profit margin 0%
Book value $1.50
Market capitalisation $38.1 million

TTM: trailing 12 months

Galmed Pharmaceuticals share dividends

We're not expecting Galmed Pharmaceuticals to pay a dividend over the next 12 months.

Galmed Pharmaceuticals share price volatility

Over the last 12 months, Galmed Pharmaceuticals's shares have ranged in value from as little as $1.311 up to $6.25. A popular way to gauge a stock's volatility is its "beta".

GLMD.US volatility(beta: 1.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Galmed Pharmaceuticals's is 1.9863. This would suggest that Galmed Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Galmed Pharmaceuticals overview

Galmed Pharmaceuticals Ltd. , a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Galmed Pharmaceuticals Ltd. has a research agreement with Gannex Pharma Co.

Frequently asked questions

What percentage of Galmed Pharmaceuticals is owned by insiders or institutions?
Currently 14.005% of Galmed Pharmaceuticals shares are held by insiders and 18.122% by institutions.
How many people work for Galmed Pharmaceuticals?
Latest data suggests 18 work at Galmed Pharmaceuticals.
When does the fiscal year end for Galmed Pharmaceuticals?
Galmed Pharmaceuticals's fiscal year ends in December.
Where is Galmed Pharmaceuticals based?
Galmed Pharmaceuticals's address is: 16 Tiomkin Street, Tel Aviv, Israel, 6578317
What is Galmed Pharmaceuticals's ISIN number?
Galmed Pharmaceuticals's international securities identification number is: IL0011313900
What is Galmed Pharmaceuticals's CUSIP number?
Galmed Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: M47238106

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site